search
Back to results

Snacking, Satiety &Weight: A Randomized, Controlled Trial (Snack)

Primary Purpose

Obesity

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
KIND Bars
Typical American Snack
Sponsored by
Griffin Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Obesity focused on measuring obesity, snacks, satiety, hunger

Eligibility Criteria

25 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Man or woman age 25-75 years;
  • Non-smoker;
  • Sedentary;
  • Overweight (BMI ≥25kg/m²) with waist circumference >40 inches (102 cm) for men and >35 inches (88 cm) for women;
  • Interested in losing weight, but not actively involved with a diet or weight loss program.
  • Snack regularly with pre-packaged snacks typically available in grocery stores or vending machines.
  • Willing to consume snacks on a daily basis.

Exclusion Criteria:

  • Failure to meet inclusion criteria;
  • Anticipated inability to complete study protocol for any reason;
  • Current eating disorder;
  • Diabetes;
  • Sleep apnea;
  • Actively involved with a diet or weight loss program;
  • Other restricted diets due to allergy/intolerance (i.e. nut, gluten) or by choice (i.e., vegetarian, vegan);
  • Regular exercise as defined by participating in moderate-intensity for at least 150 minutes/week.

Sites / Locations

  • Yale-Griffin Prevention Research Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

KIND Bar

Typical American Snack

Arm Description

Daily inclusion of KIND Bars with almonds as a primary ingredient as part of the participant's usual diet, with diet counseling to adjust for the calories from the KIND Bars. KIND Bars that we will use in the study will include: Dark Chocolate Chili Almond; Cranberry Almond; Almond Walnut Macadamia; Pomegranate Blueberry Pistachio; Nut Delight; Fruit and Nut Delight; Almond and Apricot; Blueberry Pecan and Fiber.

Daily inclusion of conventional snacks (as part of the participant's usual diet, with diet counseling to adjust for the calories from the snacks. The snacks will consist of cookies considered to be conventional snack foods that are nutrient-dilute (i.e. relatively low in nutrients) and energy-dense (i.e., relatively high in kcal). Examples of conventional snack foods will include: Nabisco Snackwell Creme Sandwich 1.7 oz pack, Nabisco Newtons Fig 2 oz pack, Nabisco Cips Ahoy! Chocolate Chip 1.4 oz pack, and Nabisco Oreo Double Stuff Chocolate 1.3 oz pack.

Outcomes

Primary Outcome Measures

Body Mass Index
Body mass index (BMI) will be calculated as weight (kg) divided by height in meters (m) squared. Waist circumference will be measured using guidelines of the National Obesity Expert Panel Report.

Secondary Outcome Measures

Body Composition
Body composition will be measured using bioelectrical impedance analysis, which uses the resistance of electrical flow through the body to estimate body fat. The Body Composition Analyzer measures weight and calculates body fat% and total body water% in addition to BMI.
Waist circumference
The waist circumference will be measured using the U.S. government standard protocol. Waist circumference will be measured around the narrowest point between ribs and hips when viewed from the front after exhaling.
Blood Pressure
Blood pressure will be measured by using a Dinamap Monitor Pro 100 (after sitting for 5 minutes). Both systolic and diastolic pressures will be calculated as the mean value of 2 readings 5 minutes apart for each participant at every time point of assessment.
Lipid Profile
The lipid profile is determined as follows: Total cholesterol , triglycerides, and high-density lipoprotein are obtained by direct measurements. Very-low-density lipoprotein (VLDL) and low-density-lipoprotein (LDL) are obtained by calculation.
Diet quality/key nutrients
Diet quality as measured by the Healthy Eating Index-2005 (HEI). A 24-hour recall will be used to assess dietary intake of all participants, and we will calculate an HEI score from each completed recall.
Hunger/Satiety
Hunger and satiety will be assessed using a Visual Analog Scale (VAS) which will ask participants a series of questions to be completed at a predetermined time relative to consumption of the treatment snack. The questions of the VAS require participants to rate on a scale the strength of specific sensations that they are feeling (i.e., hunger, thirst, amount of food that they could eat "right now", nausea, and fullness) by placing a vertical mark on the scale in response to each question.
Quality of Life
The Short Form (SF)-12 version 2.0 will be used to assess quality of life of our study participants. The SF-12 contains 12 items from the SF-36 Health Survey. The SF-12 contains one or two items that measure each of the eight concepts included in the SF-36. Like the SF-36, the SF-12 is available in standard (4-week recall) and acute (1-week recall) formats. The SF-12 standard will be used to assess the quality of life of participants.
Physical Activity
Physical activity will be assessed by the International Physical Activity Questionnaire (IPAQ) Short Form. The IPAQ is a valid and reliable tool to assess physical activity in adults. It is a more comprehensive tool containing information on weekly activities in household and yard-work activities, occupational activity, transport, leisure time physical activity and sedentary behavior.

Full Information

First Posted
November 6, 2013
Last Updated
March 25, 2020
Sponsor
Griffin Hospital
Collaborators
Kind LLC
search

1. Study Identification

Unique Protocol Identification Number
NCT02050165
Brief Title
Snacking, Satiety &Weight: A Randomized, Controlled Trial
Acronym
Snack
Official Title
Snacking, Satiety &Weight: A Randomized, Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Completed
Study Start Date
April 2012 (undefined)
Primary Completion Date
December 2013 (Actual)
Study Completion Date
December 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Griffin Hospital
Collaborators
Kind LLC

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Proposed is a parallel-design randomized controlled trial to compare the effects of consuming two types of snacks on a daily basis for a 12-week period on health outcomes, diet quality, and self-reported satiety in a group of overweight adults. The types of snacks to be studied are KIND snack bars with almonds and typical American snack foods).
Detailed Description
Snacking has been implicated in the obesity epidemic, but judicious snacking can help control appetite and calorie intake and add nutrient-dense foods to the diet. The investigators hypothesize that snacking on nutrient-dense, highly satiating snack foods (i.e. KIND snacks with almonds) as compared to snacking on nutrient-dilute, energy-dense foods (i.e., conventional snack foods) will contribute to satiety, weight loss, and health improvements. The investigators further hypothesize that the benefits of healthful snacking are enhanced when portion is clearly defined and controlled by packaging. Finally, the investigators hypothesize that these effects will be seen even when study participants are given clear guidance about the calorie content of snack items, and how to make room for those calories in their diets. Hypotheses: Snacking on nutrient-dense, highly satiating snack foods (i.e. KIND snacks with almonds) as compared to snacking on nutrient-dilute, energy-dense foods (i.e., conventional snack foods) will contribute to satiety, weight loss, and health improvements. The benefits of healthful snacking are enhanced when portion size is clearly defined and controlled by packaging. These effects will be seen even when study participants are given clear guidance about the calorie content of snack items, and how to make room for those calories in their diets.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
obesity, snacks, satiety, hunger

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
34 (Actual)

8. Arms, Groups, and Interventions

Arm Title
KIND Bar
Arm Type
Experimental
Arm Description
Daily inclusion of KIND Bars with almonds as a primary ingredient as part of the participant's usual diet, with diet counseling to adjust for the calories from the KIND Bars. KIND Bars that we will use in the study will include: Dark Chocolate Chili Almond; Cranberry Almond; Almond Walnut Macadamia; Pomegranate Blueberry Pistachio; Nut Delight; Fruit and Nut Delight; Almond and Apricot; Blueberry Pecan and Fiber.
Arm Title
Typical American Snack
Arm Type
Experimental
Arm Description
Daily inclusion of conventional snacks (as part of the participant's usual diet, with diet counseling to adjust for the calories from the snacks. The snacks will consist of cookies considered to be conventional snack foods that are nutrient-dilute (i.e. relatively low in nutrients) and energy-dense (i.e., relatively high in kcal). Examples of conventional snack foods will include: Nabisco Snackwell Creme Sandwich 1.7 oz pack, Nabisco Newtons Fig 2 oz pack, Nabisco Cips Ahoy! Chocolate Chip 1.4 oz pack, and Nabisco Oreo Double Stuff Chocolate 1.3 oz pack.
Intervention Type
Dietary Supplement
Intervention Name(s)
KIND Bars
Intervention Description
Consumption of KIND Bars for 12 weeks
Intervention Type
Dietary Supplement
Intervention Name(s)
Typical American Snack
Intervention Description
Consumption of typical American snacks for 12 weeks
Primary Outcome Measure Information:
Title
Body Mass Index
Description
Body mass index (BMI) will be calculated as weight (kg) divided by height in meters (m) squared. Waist circumference will be measured using guidelines of the National Obesity Expert Panel Report.
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Body Composition
Description
Body composition will be measured using bioelectrical impedance analysis, which uses the resistance of electrical flow through the body to estimate body fat. The Body Composition Analyzer measures weight and calculates body fat% and total body water% in addition to BMI.
Time Frame
12 Week
Title
Waist circumference
Description
The waist circumference will be measured using the U.S. government standard protocol. Waist circumference will be measured around the narrowest point between ribs and hips when viewed from the front after exhaling.
Time Frame
12 Week
Title
Blood Pressure
Description
Blood pressure will be measured by using a Dinamap Monitor Pro 100 (after sitting for 5 minutes). Both systolic and diastolic pressures will be calculated as the mean value of 2 readings 5 minutes apart for each participant at every time point of assessment.
Time Frame
12 Week
Title
Lipid Profile
Description
The lipid profile is determined as follows: Total cholesterol , triglycerides, and high-density lipoprotein are obtained by direct measurements. Very-low-density lipoprotein (VLDL) and low-density-lipoprotein (LDL) are obtained by calculation.
Time Frame
12 Week
Title
Diet quality/key nutrients
Description
Diet quality as measured by the Healthy Eating Index-2005 (HEI). A 24-hour recall will be used to assess dietary intake of all participants, and we will calculate an HEI score from each completed recall.
Time Frame
12 week
Title
Hunger/Satiety
Description
Hunger and satiety will be assessed using a Visual Analog Scale (VAS) which will ask participants a series of questions to be completed at a predetermined time relative to consumption of the treatment snack. The questions of the VAS require participants to rate on a scale the strength of specific sensations that they are feeling (i.e., hunger, thirst, amount of food that they could eat "right now", nausea, and fullness) by placing a vertical mark on the scale in response to each question.
Time Frame
12 Week
Title
Quality of Life
Description
The Short Form (SF)-12 version 2.0 will be used to assess quality of life of our study participants. The SF-12 contains 12 items from the SF-36 Health Survey. The SF-12 contains one or two items that measure each of the eight concepts included in the SF-36. Like the SF-36, the SF-12 is available in standard (4-week recall) and acute (1-week recall) formats. The SF-12 standard will be used to assess the quality of life of participants.
Time Frame
12 Week
Title
Physical Activity
Description
Physical activity will be assessed by the International Physical Activity Questionnaire (IPAQ) Short Form. The IPAQ is a valid and reliable tool to assess physical activity in adults. It is a more comprehensive tool containing information on weekly activities in household and yard-work activities, occupational activity, transport, leisure time physical activity and sedentary behavior.
Time Frame
12 week

10. Eligibility

Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Man or woman age 25-75 years; Non-smoker; Sedentary; Overweight (BMI ≥25kg/m²) with waist circumference >40 inches (102 cm) for men and >35 inches (88 cm) for women; Interested in losing weight, but not actively involved with a diet or weight loss program. Snack regularly with pre-packaged snacks typically available in grocery stores or vending machines. Willing to consume snacks on a daily basis. Exclusion Criteria: Failure to meet inclusion criteria; Anticipated inability to complete study protocol for any reason; Current eating disorder; Diabetes; Sleep apnea; Actively involved with a diet or weight loss program; Other restricted diets due to allergy/intolerance (i.e. nut, gluten) or by choice (i.e., vegetarian, vegan); Regular exercise as defined by participating in moderate-intensity for at least 150 minutes/week.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David L. Katz, MD, MPH
Organizational Affiliation
Yale-Griffin Prevention Research Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Valentine Y. Njike, MD, MPH
Organizational Affiliation
Yale-Griffin Preventin Research Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Yale-Griffin Prevention Research Center
City
Derby
State/Province
Connecticut
ZIP/Postal Code
06418
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Snacking, Satiety &Weight: A Randomized, Controlled Trial

We'll reach out to this number within 24 hrs